UK Markets close in 7 hrs 59 mins

Vifor Pharma AG (GNHAY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
26.800.00 (0.00%)
At close: 9:49AM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 58.69B
Enterprise value 39.01B
Trailing P/E 22.27
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)4.93
Price/book (mrq)2.43
Enterprise value/revenue 35.11
Enterprise value/EBITDA 717.55

Trading information

Stock price history

Beta (5Y monthly) 1.30
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 332.10
52-week low 325.81
50-day moving average 328.15
200-day moving average 328.33

Share statistics

Avg vol (3-month) 380
Avg vol (10-day) 314
Shares outstanding 5324.28M
Implied shares outstanding 6N/A
Float 233.02M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.44
Forward annual dividend yield 41.65%
Trailing annual dividend rate 32.00
Trailing annual dividend yield 37.46%
5-year average dividend yield 4N/A
Payout ratio 460.71%
Dividend date 326 May 2021
Ex-dividend date 409 May 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 20.41%
Operating margin (ttm)17.78%

Management effectiveness

Return on assets (ttm)3.86%
Return on equity (ttm)6.13%

Income statement

Revenue (ttm)1.76B
Revenue per share (ttm)5.43
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)1.06B
EBITDA 513.3M
Net income avi to common (ttm)138.7M
Diluted EPS (ttm)1.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)734.4M
Total cash per share (mrq)2.27
Total debt (mrq)609.7M
Total debt/equity (mrq)15.18
Current ratio (mrq)2.96
Book value per share (mrq)11.01

Cash flow statement

Operating cash flow (ttm)423.8M
Levered free cash flow (ttm)79.34M